157
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and liver uptake of three Schisandra lignans in rats after oral administration of liposome encapsulating β-cyclodextrin inclusion compound of Schisandra extract

, , , , , , & show all
Pages 121-132 | Received 23 Nov 2017, Accepted 16 Jan 2018, Published online: 01 Mar 2019

References

  • Allijn, I.E., Schiffelers, R.M., and Storm, G., 2016. Comparison of pharmaceutical nanoformulations for curcumin: enhancement of aqueous solubility and carrier retention. International Journal of Pharmaceutics, 506, 407–413.
  • Bilensoy, E., et al., 2008. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery. International Journal of Pharmaceutics, 347, 163–170.
  • Blanford, W.J., et al., 2014. Solubility enhancement and QSPR correlations for polycyclic aromatic hydrocarbons complexation with alpha, beta, and gamma cyclodextrins. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 78, 415–427.
  • Chiu, P.Y., and Ko, K.M., 2006. Schisandrin B-induced increase in cellular glutathione level and protection against oxidant injury are mediated by the enhancement of glutathione synthesis and regeneration in AML12 and H9c2 cells. Biofactors, 26, 221–230.
  • Foster, T., et al., 2011. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis heart study randomized clinical trial. American Journal of Gastroenterology, 106, 71–77.
  • Gharib, R., et al., 2017. Drug-in-cyclodextrin-in-liposomes as a carrier system for volatile essential oil components: application to anethole. Food Chemistry, 218, 365–371.
  • Hwang, I.S., et al., 2013. Protective effects of gomisin A isolated from Schisandra chinensis against CCl4-induced hepatic and renal injury. International Journal of Molecular Medicine, 31, 888–898.
  • Jang, M.K., et al., 2016. Schisandra chinensis extract ameliorates nonalcoholic fatty liver via inhibition of endoplasmic reticulum stress. Journal of Ethnopharmacology, 185, 96–104.
  • Niu, J., et al., 2017. In Vitro antioxidant activities and anti-diabetic effect of a polysaccharide from Schisandra sphenanthera in rats with type 2 diabetes. International Journal of Biological Macromolecules, 94, 154–160.
  • Jiang, Y.M., et al., 2015. Hepato-protective effects of six Schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation. Chemico-Biological Interactions, 231, 83–89.
  • Li, B., et al., 2015. Effects of Triterpenoid from Schisandra chinensis on oxidative stress in alcohol-induced liver injury in rats. Cell Biochemistry and Biophysics, 71, 803–811.
  • Lima, P.S.S., et al., 2016. Inclusion of terpenes in cyclodextrins: Preparation, characterization and pharmacological approaches. Carbohydrate Polymers, 151, 965–987.
  • Liu, H.T., et al., 2015. Extracts and lignans of Schisandra chinensis fruit alter lipid and glucose metabolism in vivo and in vitro. Journal of Functional Foods, 19, 296–307.
  • Liu, X.N., et al., 2013. Clarithromycin-loaded liposomes offering high drug loading and less irritation. International Journal of Pharmaceutics, 443, 318–327.
  • Mangolim, C.S., et al., 2014. Curcumin-beta-cyclodextrin inclusion complex: stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction, and photoacoustic spectroscopy, and food application. Food Chemistry, 153, 361–370.
  • Manosroi, J., et al., 2005. Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin. International Journal of Pharmaceutics, 293, 235–240.
  • Mohandoss, S., et al., 2016. Host-guest molecular recognition based fluorescence On-Off-On chemosensor for nanomolar level detection of Cu2+ and Cr2O72- ions: application in XNOR logic gate and human lung cancer living cell imaging. Sensors and Actuators B-Chemical, 234, 300–315.
  • Paczkowska, M., et al., 2016. Beta-cyclodextrin complexation as an effective drug delivery system for meropenem. European Journal of Pharmaceutics and Biopharmaceutics, 99, 24–34.
  • Pathak, P., et al., 2016. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: in silico modeling, in vitro, and in vivo evaluation. International Journal of Pharmaceutics, 509, 149–158.
  • Ren, L.L., et al., 2014. Preparation and pharmacokinetic study of aprepitant-sulfobutyl ether-β-cyclodextrin complex. Aaps Pharmscitech, 15, 121–130.
  • Sanghvi, R., Evans, D., and Yalkowsky, S.H., 2007. Stacking complexation by nicotinamide: A useful way of enhancing drug solubility. International Journal of Pharmaceutics, 336, 35–41.
  • Shim, G., et al., 2017. Nanoformulation-based sequential combination cancer therapy. Advanced Drug Delivery Reviews, 115, 57–81.
  • Sintov, A.C., Levy, H.V., and Botner, S., 2010. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies. Journal of Controlled Release, 148, 168–176.
  • Tiwari, G., Tiwari, R., and Rai, A.K., 2010. Cyclodextrins in delivery systems: applications. Journal of Pharmacy and Amp; Bioallied Sciences, 2, 72–79.
  • Wang, W.X., Feng, S.S., and Zheng, C.H., 2016. A comparison between conventional liposome and drug-cyclodextrin complex in liposome system. International Journal of Pharmaceutics, 513, 387–392.
  • Xie, C.L., et al., 2016. Preparation and optimisation of liposome-in-alginate beads containing oyster hydrolysate for sustained release. International Journal of Food Science and Technology, 51, 2209–2216.
  • Yang, T., et al., 2015. Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe. Journal of Ethnopharmacology, 166, 305–312.
  • Ye, J.F., et al., 2016. Monkey is the suitable animal model for pharmacoketic study of Schisanhenol in humans. Latin American Journal of Pharmacy, 35, 616–619.
  • Zhu, Y., et al., 2015. Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats. Archives of Pharmacal Research, 38, 512–521.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.